Harvard Bio and Molecular Devices Fall as BCW Index Climbs 2 Percent

The share price of Harvard Bioscience fell 3.6 percent for the five-day period ending Tuesday, while Molecular Devices fell 2 percent as the only two losers among the 15 companies tracked in the BioCommerce Week Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.